Inogen Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Kevin R. Smith

İcra Kurulu Başkanı

US$2.4m

Toplam tazminat

CEO maaş yüzdesi4.4%
CEO görev süresiless than a year
CEO sahipliğin/a
Yönetim ortalama görev süresiless than a year
Yönetim Kurulu ortalama görev süresi2.7yrs

Son yönetim güncellemeleri

Recent updates

Inogen: Upside Seems Limited After Big Move Up

Sep 24

Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jul 16
Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Inogen: Improving, But Still Struggling For Air

Jul 01

Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

May 22
Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities

Apr 13

Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target

Mar 01
Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target

Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%

Feb 01
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%

Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?

Oct 06
Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?

Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Jun 21
Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?

Mar 14
Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?

Companies Like Inogen (NASDAQ:INGN) Can Afford To Invest In Growth

Oct 27
Companies Like Inogen (NASDAQ:INGN) Can Afford To Invest In Growth

Inogen, Inc.'s (NASDAQ:INGN) Intrinsic Value Is Potentially 64% Above Its Share Price

Sep 20
Inogen, Inc.'s (NASDAQ:INGN) Intrinsic Value Is Potentially 64% Above Its Share Price

Inogen: Structural, Supply Chain Headwinds Remain

Sep 13

Inogen Non-GAAP EPS of -$0.02 beats by $0.31, revenue of $103.38M beats by $2.74M

Aug 04

Inogen: Seasonal FCF, Tightening Margins, Supply Chain Headwinds

Jun 14

At US$35.28, Is It Time To Put Inogen, Inc. (NASDAQ:INGN) On Your Watch List?

Apr 03
At US$35.28, Is It Time To Put Inogen, Inc. (NASDAQ:INGN) On Your Watch List?

Hammered By Supply Issues, Inogen Could Be A 2023 Comeback Story

Mar 31

Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 28% Undervaluation?

Mar 09
Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 28% Undervaluation?

CEO Tazminat Analizi

Kevin R. Smith'un ücretlendirmesi Inogen'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$53m

Jun 30 2024n/an/a

-US$92m

Mar 31 2024n/an/a

-US$97m

Dec 31 2023US$2mUS$108k

-US$102m

Tazminat ve Piyasa: Kevin R. 'nin toplam tazminatı ($USD 2.45M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.46M ).

Tazminat ve Kazançlar: Kevin R. şirketinin tazminatını şirket performansıyla karşılaştırmak için yeterli veri yok.


CEO

Kevin R. Smith (53 yo)

less than a year

Görev süresi

US$2,448,754

Tazminat

Mr. Kevin R. M. Smith serves as President, Chief Executive Officer and Director at Inogen Inc. since November 13, 2023. He served as Director at OncoSec Medical Incorporated since February 7, 2020 until Ju...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Kevin R. Smith
Presidentless than a yearUS$2.45mVeri yok
Michael Bourque
Executive VPless than a yearVeri yokVeri yok
Philip Corrin
Senior Vice President of Operations & Supply Chain1.8yrsVeri yokVeri yok
Kevin Smith
General Counsel & Executive VP of Business Developmentless than a yearVeri yokVeri yok
Jennifer Boyer
Executive VP & Chief Human Resources Officer2.5yrsVeri yokVeri yok
Grgoire Ramade
Executive VP & Chief Commercial Officerless than a yearVeri yokVeri yok
Krishna Jhaveri
Chief Medical Officerless than a yearVeri yokVeri yok
Paul Andreassi
Senior Vice President of Quality & Regulatory Affairsless than a yearVeri yokVeri yok
Adrien Mithalal
Senior Vice President of Research & Developmentless than a yearVeri yokVeri yok

0.8yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim: INGN 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.8 yıl), bu da yeni bir ekibin varlığını gösteriyor.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Kevin R. Smith
Presidentless than a yearUS$2.45mVeri yok
Richard Casaburi
Member of Advisory Boardno dataVeri yokVeri yok
Jeffrey Kupperman
Member of Advisory Boardno dataVeri yokVeri yok
Paul Selecky
Member of Advisory Boardno dataVeri yokVeri yok
Mary Ladone
Independent Director2.7yrsUS$242.50k0.10%
$ 230.8k
Kevin King
Independent Director2.7yrsUS$250.00k0.10%
$ 230.8k
Neil MacIntyre
Member of Advisory Boardno dataVeri yokVeri yok
Elizabeth Mora
Independent Board Chairperson3.5yrsUS$315.00k0.11%
$ 252.6k
Robert Chatburn
Member of Advisory Boardno dataVeri yokVeri yok
Thomas West
Independent Director1.6yrsUS$266.24k0.079%
$ 177.9k
Heather Rider
Independent Director10.3yrsUS$242.50k0.16%
$ 356.8k
Glenn Boehnlein
Independent Director2.7yrsUS$250.00k0.10%
$ 230.8k

2.7yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: INGN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.7 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.